C
Cai Liang
Researcher at The Chinese University of Hong Kong
Publications - 4
Citations - 85
Cai Liang is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Endothelial stem cell & Embryonic stem cell. The author has an hindex of 4, co-authored 4 publications receiving 48 citations.
Papers
More filters
Journal ArticleDOI
Specific ablation of CD4 + T-cells promotes heart regeneration in juvenile mice.
Jiatao Li,Cai Liang,Kevin Y. Yang,Xiuzhen Huang,Mao Ying Han,Xisheng Li,Vicken W. Chan,Kathleen S Chan,Di Liu,Zhan-Peng Huang,Bin Zhou,Kathy O. Lui +11 more
TL;DR: It is demonstrated that ablation of CD4+ but not CD8+ T-cells promotes heart regeneration in juvenile mice; and CD4-cells play a distinct role in the regulation of heart regeneration and repair during development.
Journal ArticleDOI
CD8+ T-cell plasticity regulates vascular regeneration in type-2 diabetes.
Cai Liang,Kevin Y. Yang,Vicken W. Chan,Xisheng Li,Tiffany H.W. Fung,Yalan Wu,Xiao Yu Tian,Yu Huang,Ling Qin,James Y.W. Lau,Kathy O. Lui +10 more
TL;DR: The results reveal that CD8+ T-cell plasticity regulates vascular regeneration; and give clinically relevant insights into the potential development of immunotherapy targeting vascular diseases associated with obesity and diabetes.
Journal ArticleDOI
Endothelial cell transient receptor potential channel C5 (TRPC5) is essential for endothelium-dependent contraction in mouse carotid arteries.
Cai Liang,Yunting Zhang,Duan Zhuo,Chun-Yin Lo,Libo Yu,Chi Wai Lau,Yiu Wa Kwan,Gary Tse,Yu Huang,Xiaoqiang Yao +9 more
TL;DR: It is demonstrated that TRPC5 in endothelial cells contributes to EDC by stimulating the production of COX‐2‐linked prostanoids.
Journal ArticleDOI
Coreceptor blockade targeting CD4 and CD8 allows acceptance of allogeneic human pluripotent stem cell grafts in humanized mice
Jiatao Li,Xisheng Li,Cai Liang,Lijun Ling,Zhiwei Chen,Chun-Kwok Wong,Herman Waldmann,Kathy O. Lui +7 more
TL;DR: The results give support to the principle that short-term blockade of T-cell co-receptors can achieve long-term acceptance of regenerative cell transplants in humans.